London

27^th November 2007

WORLD-RENOWNED NEUROLOGY EXPERT JOINS NEW ISRAELI AMBASSADOR AND GOLDWASSER FAMILY AT

RON ARAD LECTURE

World-renowned neurology expert, Professor Moussa Youdim of the Technion- Israel Institute of Technology, whose research has led to the most advanced treatment for Parkinson’s disease, gave the prestigious Ron Arad Lecture in London on Monday evening. Professor Youdim was joined by the new Israel Ambassador to London, Ron Proser, and the family of kidnapped Technion student, Ehud Goldwasser.

300 guests filled the Royal College of Physicians to hear from Professor Youdim, Director of the Eve Topf Neurodegenerative Disease Center at the Technion, who discussed the science behind Parkinson’s and Alzheimer’s diseases, his discovery of anti-Parkinson drug rasagiline and the novel new drugs currently under development which will transform the lives of sufferers in the future. Karnit Goldwasser, wife of Ehud Goldwasser closed the lecture with an update on her husband’s plight and called for guests to raise their voices to Government and the UN to demand that they do everything they can to ensure his safe return.

At the dinner which followed, HE Mr. Proser applauded the Technion’s work as a shining example of Israel’s prominence in the field of science and technology and cited how he intended to use his time in the UK to highlight Israel’s positive contribution on the global stage.

On Monday afternoon, Professor Youdim gave a masterclass at the Science Museum to over 120 students from schools across London about his incredible research.

His Excellency, Ron Proser, Israel’s Ambassador commented: “The British Technion Society has been instrumental in showing the UK what the Technion has to offer in the way of technological advancement.

“The Technion is at the heart of Israel’s high-tech industry and it has made a great contribution to Israel’s prosperity. Israel is a tiny country but the Technion proves that in terms of science and education, we can stand shoulder to shoulder with giants.”

Lois Peltz, Co-Chair of the British Technion Society, said: “Professor Youdim’s research once again places the Technion at the forefront of scientific attainment. We owe him a debt of gratitude for his research, which gives hope to the thousands of new patients diagnosed each year with neurodegenerative diseases.”